Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

That’s biotech though Dunn. Look at that Onxeo and validive deal. That sat for years after a phase 2 completion until last September where Monopar Therapeutics licensed it and moved it to phase 3. Or maybe it was soligenix. I can’t recall - but one sat on the shelf for 2 years.

The good thing. There is zero debt and we have plenty of capital that can be raised. We still have Prurisol data, Kevetrin data, and B-OM final report to allow FDA BTD submission in the near term.

I expect a deal for something this year. I will be extremely disappointed if that is not the case.

Oral K may spark it all...who knows.

IMO.